QT
CYTK icon

Quantbot Technologies’s Cytokinetics CYTK Stock Holding History

Quantbot Technologies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,593
Closed -$112K – 1537
2024
Q1 		$112K Buy
+1,593
New +$123K 0.01% 1144
2022
Q2 		– Sell
-1,568
Closed -$57K – 1775
2022
Q1 		$57K Sell
1,568
-12,180
-89% -$433K 0.01% 1170
2021
Q4 		$626K Sell
13,748
-8,288
-38% -$320K 0.05% 474
2021
Q3 		$787K Buy
+22,036
New +$649K 0.06% 459
2021
Q2 		– Sell
-1,900
Closed -$44K – 1524
2021
Q1 		$44K Buy
+1,900
New +$40.6K ﹤0.01% 1036
2020
Q4 		– Sell
-1,600
Closed -$34K – 1366
2020
Q3 		$34K Buy
1,600
+1,100
+220% +$25.7K ﹤0.01% 921
2020
Q2 		$11K Buy
+500
New +$9.38K ﹤0.01% 912
2019
Q3 		– Sell
-700
Closed -$7K – 1327
2019
Q2 		$7K Buy
+700
New +$6.75K ﹤0.01% 1110
2018
Q1 		– Sell
-2,577
Closed -$21K – 1263
2017
Q4 		$21K Buy
+2,577
New +$29.3K ﹤0.01% 1065
2017
Q3 		– Sell
-4,708
Closed -$56K – 1236
2017
Q2 		$56K Buy
+4,708
New +$65.4K 0.01% 892
2016
Q1 		– Sell
-9,419
Closed -$98K – 1191
2015
Q4 		$98K Buy
+9,419
New +$92.4K 0.02% 653

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Quantbot Technologies's CYTK Position: Q2 2024 in Review

Quantbot Technologies sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 1,593 shares — an estimated $112K sold.

Quantbot Technologies first reported a position in CYTK in Q4 2015 and held it in 11 quarters. The position peaked at $787K in Q3 2021. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Quantbot Technologies reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,593 Cytokinetics shares in Q2 2024, an estimated $112K.
  • Quantbot Technologies first reported a position in Cytokinetics in Q4 2015 and held it in 11 quarters.
  • Quantbot Technologies's Cytokinetics position peaked at $787K in Q3 2021.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.